Process View
The series of molecular signals generated as a consequence of a dopamine receptor binding to its physiological ligand, where the pathway proceeds with inhibition of adenylyl cyclase and a subsequent decrease in the concentration of cyclic AMP (cAMP).

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "adenylate cyclase inhibiting dopamine receptor signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FLNA | filamin A, alpha | 0.838 | ||
| FLNB | filamin B, beta | 0.753 | Human | |
| MYH9 | myosin, heavy chain 9, non-muscle | 0.230 | ||
| PSEN1 | presenilin 1 | 0.186 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.137 | ||
| SGCD | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) | 0.135 | ||
| SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.073 | ||
| XIRP1 | xin actin-binding repeat containing 1 | 0.067 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.051 | ||
| ADORA2A | adenosine A2a receptor | 0.043 | ||
| ACTN4 | actinin, alpha 4 | 0.043 | ||
| ACTN1 | actinin, alpha 1 | 0.039 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.038 | ||
| LMNA | lamin A/C | 0.037 | ||
| FN1 | fibronectin 1 | 0.036 | ||
| SGCG | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | 0.034 | ||
| FBLIM1 | filamin binding LIM protein 1 | 0.019 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.016 | ||
| ITGB7 | integrin, beta 7 | 0.013 | ||
| ZYX | zyxin | 0.012 | ||
| MYOZ1 | myozenin 1 | 0.011 |